logologo
QuantliQuantli

BioCryst Pharmaceuticals Inc

BCRX

NASDAQ

Biotechnology

$9.74

USD

-0.07 (-0.71%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $2.52B

Volume 3.8M

Price Target

$12.00$32.00

USD

The 3 analysts offering 1-year price forecasts have a max estimate of $32.00 and a min estimate of $12.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$24.33

+$2.7 vs prior

Implied Upside

+149.8%

+27.3% vs prior

Analyst Covering

3

Unchanged vs prior period

Consensus

Hold

Declined vs prior

Signal Quality

Consensus Freshness

50%

A mix of recent and older ratings shape this consensus

Analyst Agreement

Low

Targets are widely dispersed - limited agreement on price

Mean vs Median

$4.67 Gap

Median $29.00 vs avg $24.33 - a few cautious outliers are pulling the average down

Analyst Consensus

Strong Sell

Hold

Strong Buy

Hold

2 Buy

1 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

2

Hold

1

Sell

0

Strong Sell

0

3 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Jessica Fye

JP Morgan

Hold

Resumed

4 weeks ago

Plus
Plus
Plus

Steven Seedhouse

Raymond James

Buy

Maintained

1 month ago

Plus
Plus
Plus

Andrew S. Fein

HC Wainwright & Co.

Buy

Maintained

1 month ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

BEAM

Beam Therapeutics Inc

$26.75

+0.9%

SLS

Sellas Life Sciences Group Inc

$12.78

+3.4%

PVLA

Palvella Therapeutics Inc

$156.13

-0.3%

CDNA

CareDx Inc

$45.32

-4.3%

VCEL

Vericel Corp

$44.20

-0.8%

COAG

Hemab Therapeutics Holdings Inc

$54.94

+1.8%

KOD

Kodiak Sciences Inc

$41.35

+3.4%

MLYS

Mineralys Therapeutics Inc

$25.64

-1.7%

VERA

Vera Therapeutics, Inc

$31.63

+9.5%

RARE

Ultragenyx Pharmaceutical Inc

$26.49

+0.4%

KLRA

Kailera Therapeutics Inc

$17.94

-0.2%